HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study.

AuthorsTadaaki Nishikawa, Kosei Hasegawa, Akira Yabuno, Hiroyuki Yoshida, Masanori Yasuda, Eito Kozawa, Keiichi Fujiwara
JournalJournal of gynecologic oncology (J Gynecol Oncol) Vol. 28 Issue 1 Pg. e25 (Jan 2017) ISSN: 2005-0399 [Electronic] Korea (South)
PMID27958685 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib
Topics
  • Aged
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Carcinosarcoma (diagnostic imaging, drug therapy)
  • Female
  • Humans
  • Indazoles
  • Middle Aged
  • Ovarian Neoplasms (diagnostic imaging, drug therapy)
  • Pyrimidines (administration & dosage, adverse effects)
  • Sulfonamides (administration & dosage, adverse effects)
  • Tomography, X-Ray Computed
  • Uterine Neoplasms (diagnostic imaging, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: